Purinergic signalling: past, present and future [PDF]
The discovery of non-adrenergic, non-cholinergic neurotransmission in the gut and bladder in the early 1960's is described as well as the identification of adenosine 5'-triphosphate (ATP) as a transmitter in these nerves in the early 1970's.
G. Burnstock
doaj +2 more sources
Extracellular ATP triggers proteolysis and cytosolic Ca2+ rise in
Background Plasmodium has a complex cell biology and it is essential to dissect the cell-signalling pathways underlying its survival within the host. Methods Using the fluorescence resonance energy transfer (FRET) peptide substrate Abz-AIKFFARQ-EDDnp and
Cruz Laura +6 more
doaj +6 more sources
The involvement of purinergic signalling in obesity. [PDF]
Obesity is a growing worldwide health problem, with an alarming increasing prevalence in developed countries, caused by a dysregulation of energy balance.
Burnstock G, Gentile D.
europepmc +2 more sources
Purinergic signalling in the urinary bladder - When function becomes dysfunction. [PDF]
Fry CH, McCloskey KD.
europepmc +2 more sources
Purinergic signalling in spinal pain processing. [PDF]
Tam TH, Salter MW.
europepmc +2 more sources
Purinergic Signalling in Group A Streptococcus Pathogenesis [PDF]
T. B-D McEwan +5 more
doaj +2 more sources
Extracellular creatine kinase may modulate purinergic signalling. [PDF]
Brewster LM.
europepmc +2 more sources
Unmasking Adenosine: The Purinergic Signalling Molecule Critical to Arrhythmia Pathophysiology and Management [PDF]
Gareth DK Matthews, Andrew A Grace
doaj +2 more sources
Purinergic Signaling in Neuroinflammation [PDF]
ATP is stored in millimolar concentrations within the intracellular medium but may be released to extracellular sites either through the damaged plasma membrane or by means of various transporters [...]
Dmitry Aminin, Peter Illes
openaire +3 more sources
More than a drug target: Purinergic signalling as a source for diagnostic tools in epilepsy.
Epilepsy is one of the most common and disabling chronic neurological diseases affecting people of all ages. Major challenges of epilepsy management include the persistently high percentage of drug-refractoriness among patients, the absence of disease ...
Zheng Wei Wong, T. Engel
semanticscholar +1 more source

